Tatva Chintan Pharma Chem Ltd consolidated Q4 FY2024-25 PAT at Rs. 1.03 crore

Tatva Chintan Pharma Chem Ltd has reported Consolidated financial results for the period ended March 31, 2025.

Financial Results (Q4 FY2025) - QoQ Comparison

The company has reported total income of Rs. 108.586 crores during the period ended March 31, 2025 as compared to Rs. 85.940 crores during the period ended December 31, 2024.

The company has posted net profit / (loss) of Rs. 1.03 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 0.138 crores for the period ended December 31, 2024.

The company has reported EPS of Rs. 0.44 for the period ended March 31, 2025 as compared to Rs. 0.06 for the period ended December 31, 2024.

Financials	Q4 FY2025	Q3 FY2025	% Change
Total Income	₹ 108.586 crs	₹85.940 crs	26.35%
Net Profit	₹1.03 crs	₹0.138 crs	646.38%
EPS	₹0.44	₹0.06	633.33%

Financial Results (Q4 FY2025) - YoY Comparison

The company has reported total income of Rs. 108.586 crores during the period ended March 31, 2025 as compared to Rs.102.794 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs.1.03 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.9.614 crores for the period ended March 31, 2024.

The company has reported EPS of Rs.0.44 for the period ended March 31, 2025 as compared to Rs.4.11 for the period ended March 31, 2024.

Financials	Q4 FY2025	Q4 FY2024	% Change
Total Income	₹ 108.586 crs	₹102.794 crs	5.63%
Net Profit	₹1.03 crs	₹9.614 crs	-89.29%
EPS	₹0.44	₹4.11	-89.29%

Financial Results (Year Ended FY2025) - YoY Comparison

The company has reported total income of Rs.385.029 crores during the Financial Year ended March 31, 2025 as compared to Rs.401.013 crores during the Financial Year ended March 31, 2024.

The company has posted net profit / (loss) of Rs.5.713 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.30.354 crores for the Financial Year ended March 31, 2024.

The company has reported EPS of Rs.2.44 for the Financial Year ended March 31, 2025 as compared to Rs.13.26 for the Financial Year ended March 31, 2024.

Financials	Year Ended FY2025	Year Ended FY2024	% Change
Total Income	₹385.029 crs	₹401.013 crs	-3.99%
Net Profit	₹5.713 crs	₹30.354 crs	-81.18%
EPS	₹2.44	₹13.26	-81.60%

Shares of Tatva Chintan Pharma Chem Ltd was last trading in BSE at Rs. 704.05 as compared to the previous close of Rs. 706.00. The total number of shares traded during the day was 1599 in over 275 trades.

The stock hit an intraday high of Rs. 722.65 and intraday low of 700.00. The net turnover during the day was Rs. 1138512.00.

Source : Equity Bulls

Keywords

TatvaChintanPharmaChem Q4FY25 Q4FY2025 FY2025 ResultUpdate